ENTITY
Shenzhen HepaLink Pharmaceutical (H)

Shenzhen HepaLink Pharmaceutical (H) (9989 HK)

61
Analysis
Health CareChina
Shenzhen Hepalink Pharmaceutical Group Co., Ltd researches, produces and sells heparin pharmaceuticals products. The Company's products include heparin sodium active pharmaceutical ingredient.
more
14 Mar 2021 13:12

Quiddity Weekly H/A: Energy Up, Spreads Wider, Pharmas Down Spreads Narrower

Spread momentum continues unabated. Of note, CanSino's vaccine approval is getting no friends as the stock is down nearly 25% in 2 weeks and 29% in...

Logo
180 Views
Share
07 Mar 2021 21:42

Quiddity Weekly H/A: Financials Outpace Everything Else: Marketwide 87% Upside to A-Share Parity

H/A spreads were largely unchanged on the week but more widened than narrowed. Financials was the only sector narrower on the whole. With average...

Logo
226 Views
Share
28 Feb 2021 21:58

Quiddity Weekly H/A: Strong Dispersion, Strong Alpha; Brokers Beat Banks

Great alpha last week as shorts beat by 48bp, longs beat by 46bp. Southbound saw one really big sell day, but on the week, buying continued apace...

Logo
240 Views
Share
21 Feb 2021 09:22

Quiddity Weekly H/A: High Volatility in Materials and Industrials and Spreads Over Lunar New Year

H/A spreads have been reasonably volatile over the CNY period, but again they net narrowed over two weeks. There are still several sectors where...

Logo
151 Views
Share
22 Dec 2020 11:57

Hong Kong IPOs: Lock-Up Expiries (December 2020 Edition)

There exist the "moral hazard" around the expiry of lock-up periods. In 2020, IPO's have on average underperformed the HSI heading into the lock...

Logo
553 Views
Share
x